Author/Editor | Zevnik, Katarina; Blatnik, Ana; Novaković, Srdjan; Hribernik, Nežka | |
Title | CDKN2A-positive melanoma patient treated with combination immunotherapy | |
Type | članek | |
Vol. and No. | , št. Vol. 4 | |
Publication year | 2022 | |
Volume | str. [1-5] | |
ISSN | 2667-3940 | |
Language | eng | |
Abstract | Germline aberrations in the CDKN2A gene are observed in 20%‐40% of families susceptible to melanoma. Positive CDKN2A status is associated with early age of onset of melanoma, multiple primary melanomas, and pancreatic cancer. We report here a melanoma patient with a germline mutation c.68G>A p.(Gly23Asp) in CDKN2A who had a history of multiple cutaneous melanomas and a family history consistent with familial atypical multiple mole melanoma (FAMMM) syndrome. He developed oligometastatic disease with BRAF-positive melanoma metastases in soft tissue and gallbladder and was treated with surgical resection followed by combination therapy of PD-1 and CTLA-4 immune checkpoint inhibitor, which resulted in good remission. Molecular analysis of all primary melanomas and both metastatic sites revealed the same BRAF c.1799T>A p.(Val600Glu) V600E mutations. | |
Keywords | melanom kožni rak imunoterapija molekularna analiza melanoma skin cancer immunotherapy molecular analysis |